Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer (BCG/EMDA-MMC)

This study has been completed.
University of L'Aquila
Information provided by (Responsible Party):
Savino M. Di Stasi, University of Rome Tor Vergata Identifier:
First received: July 29, 2011
Last updated: September 27, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)